Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion
出版年份 2015 全文链接
标题
Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion
作者
关键词
-
出版物
Molecular Oncology
Volume 9, Issue 7, Pages 1259-1273
出版商
Wiley
发表日期
2015-03-29
DOI
10.1016/j.molonc.2015.03.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cells
- (2015) Hilal S. Khalil et al. JOURNAL OF BIOTECHNOLOGY
- Activating human genes with zinc finger proteins, transcription activator-like effectors and CRISPR/Cas9 for gene therapy and regenerative medicine
- (2014) Charles A Gersbach et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation
- (2014) Jung-Hyun Kim et al. JOURNAL OF CLINICAL INVESTIGATION
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study
- (2014) Joyce F Liu et al. LANCET ONCOLOGY
- Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation
- (2014) Matthew R. Grimmer et al. NUCLEIC ACIDS RESEARCH
- Unique Pattern of Component Gene Disruption in the NRF2 Inhibitor KEAP1/CUL3/RBX1 E3-Ubiquitin Ligase Complex in Serous Ovarian Cancer
- (2014) Victor D. Martinez et al. Biomed Research International
- Olaparib: a promising PARP inhibitor in ovarian cancer therapy
- (2013) Ying Chen et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer
- (2013) Bhupendra Singh et al. BMC CANCER
- Breaking through an epigenetic wall
- (2013) Karla Juárez-Moreno et al. Epigenetics
- Poly(ADP-ribose) polymerase-1 modulates Nrf2-dependent transcription
- (2013) Tongde Wu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Trafficking of the Transcription Factor Nrf2 to Promyelocytic Leukemia-Nuclear Bodies
- (2013) Melanie Theodore Malloy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
- (2013) Chiara Gorrini et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors
- (2013) Christian Huisman et al. Molecular Oncology
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- The Involvement ofNRF2in Lung Cancer
- (2013) Alison K. Bauer et al. Oxidative Medicine and Cellular Longevity
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- Oxidative stress and cancer: An overview
- (2012) Venus Sosa et al. AGEING RESEARCH REVIEWS
- The Predicted Molecular Weight of Nrf2: It Is What It Is Not
- (2012) Alexandria Lau et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
- (2012) Sabine Stolzenburg et al. NUCLEIC ACIDS RESEARCH
- Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
- (2012) S Chowdhry et al. ONCOGENE
- Update on PARP1 inhibitors in ovarian cancer
- (2011) C. Sessa ANNALS OF ONCOLOGY
- Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer
- (2011) Xiangdong Ma et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
- (2011) P. A. Konstantinopoulos et al. CANCER RESEARCH
- Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids
- (2011) Emilia Kansanen et al. FREE RADICAL BIOLOGY AND MEDICINE
- Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy
- (2011) Adam Lister et al. Molecular Cancer
- Tissue-Restricted Expression of Nrf2 and Its Target Genes in Zebrafish with Gene-Specific Variations in the Induction Profiles
- (2011) Hitomi Nakajima et al. PLoS One
- The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
- (2011) P. Walter et al. SCIENCE
- PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond
- (2011) Susana Banerjee et al. Current Oncology Reports
- Cellular Stress Responses, The Hormesis Paradigm, and Vitagenes: Novel Targets for Therapeutic Intervention in Neurodegenerative Disorders
- (2010) Vittorio Calabrese et al. ANTIOXIDANTS & REDOX SIGNALING
- High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer
- (2010) T. Jiang et al. CANCER RESEARCH
- Mononuclear Fe(ii)-N4Py complexes in oxidative DNA cleavage: structure, activity and mechanism
- (2010) Qian Li et al. DALTON TRANSACTIONS
- Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses inBRCACarrier Ovarian Cancer Correlating With Platinum-Free Interval
- (2010) Peter C. Fong et al. JOURNAL OF CLINICAL ONCOLOGY
- Correlation of Nrf2, HO-1, and MRP3 in Gallbladder Cancer and Their Relationships to Clinicopathologic Features and Survival
- (2010) Jiansheng Wang et al. JOURNAL OF SURGICAL RESEARCH
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
- (2010) M William Audeh et al. LANCET
- Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
- (2010) Deepti Malhotra et al. NUCLEIC ACIDS RESEARCH
- Zinc-finger-based artificial transcription factors and their applications
- (2009) Takashi Sera ADVANCED DRUG DELIVERY REVIEWS
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- TIF1β/KAP-1 Is a Coactivator of the Orphan Nuclear Receptor NGFI-B/Nur77
- (2009) Juliette Rambaud et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- RNAi-Mediated Silencing of Nuclear Factor Erythroid-2-Related Factor 2 Gene Expression in Non-Small Cell Lung Cancer Inhibits Tumor Growth and Increases Efficacy of Chemotherapy
- (2008) A. Singh et al. CANCER RESEARCH
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Dual roles of Nrf2 in cancer
- (2008) A LAU et al. PHARMACOLOGICAL RESEARCH
- Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: Implication to cancer cell resistance
- (2007) Jeong-Min Cho et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search